29/07/2024  12:10:02 Var. -1.60 Volume Denaro13:15:00 Lettera14:56:11 Capitalizzazione di mercato Dividend Y. Rapporto P/E
20.40EUR -7.27% 27
Fatturato: 550.80
-Quantità in denaro: - 21.00Quantità in lettera: 87 247.2 mill.EUR 2.18% 23.15

Descrizione business

PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments. In Germany, PharmaSGP is the market leader for systemic chemical-free pain remedies with its brand families RUBAXX® for rheumatic pain and RESTAXIL® for neuralgic pain. Furthermore, PharmaSGP has introduced leading products against sexual weakness and vertigo symptoms.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Natalie Weigand
Consiglio di amministrazione
Michael Rudolf
Consiglio di sorveglianza
Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien
 

Dati aziendali

Name: PharmaSGP Holding SE
Indirizzo: Lochhamer Schlag 21,D-82166 Gräfelfing
Telefono: +49-611-2058-5528
Fax: +49-611-2058-5566
E-mail: info@pharmasgp.com
Internet: https://pharmasgp.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: 19/06/2020

Rapporti con gli investitori

Name: Claudius Krause
IR telefono: +49-611-2058-5535
IR Fax: -
IR e-mail: ir@pharmasgp.com

Principali azionisti

FUTRUE GmbH / MVH Beteiligungs- und Beratungs-GmbH
 
77.82%
Freefloat
 
14.83%
Union Investment Privatfonds GmbH
 
4.70%
Swedbank Robur Fonder AB
 
2.65%